{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"bartter-disease-type-3","columns":[{"gene":"","key":"population-49c340585fd39dd90d7d","label":"Bartter syndrome, type 3","mondoId":"MONDO:0011822","onsetQualifier":null,"originColumnKey":"MONDO:0011822/OMIM:607364","originalViews":[{"key":"MONDO:0011822/OMIM:607364","label":"Bartter syndrome, type 3","scopeLabel":"OMIM:607364","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["10561b4ee83cc6d7660e9b3bff175aa4c381f35601b90bb3cfb44ccbf2ab58eb","137f509a83dee47e8f544343147a1eafe74b5477a1ee863dc929c4435087ab11","1f1d15bb27a8f08aeefaadefdcfa41d049e8e43057f227f38699e2aa8a8faa06","24a8a1462fdf8000d6708830a7118685662e94b63372adef1e37d3ae3052d8cb","2a4cd57a61dae2b1335c0eef5b6c680b1091fe6a4c0cab48f78def3178bcc7ab","329fe0ff3937ea560c42e9109fb0598be3334a3c0289ec3b65c318155db654ef","394c01537e055ac3c410c2002d10436301063c449b4885bf5ef455753ac393b4","43c70a61d960a36d56784dc2bf945ef006d02cb34ff6878938594a04e059c26e","694e4b23bd9e2963259d5e871ea2dcf5c1d5d1410a07ca193c93298de5ace187","69ee5150bcf367f437103314c092aeb15bee6bd75b22bda9c2389ea6c23cdded","7b101f3c4a33dafb908a8db8f0cad386340258a46b641942c76640da76cce6f7","849cdd3d54e6f2e648d3deb0c60f63b741d630ee8366d02afc45c3d66b0447b9","883a1f909a4d15280ef2d70a9f7533fd9c7e424f06302fae78a28568cd7d7f49","983c4257227bdf1ffd91609d7eef5ddf2142389c95e69d72f56c7203b1cd1049","ae351dd68c5ff270f42e19ea1569d07e27258a1edee2a0ca6303f75703406679","b8b2f2abdddbc919d37c166e135583e92bb7f72ecc4a008e1a86c54f9f7fc110","d9d4bd2e1226a3135a0ebbca9ef90a7be4728fc271d1705fb007a458ccbb60ea","f2f1e6ca893c29e3ffc0b6dd2c53d43868da70ff40444bade8eb968bcda0f42e","fb8ae9f5eaa91acf88ec91d4a2eea6f5ccbc96fc94aa9946ae087e28780a24d7"],"recordQualifiers":{},"scopeLabel":"OMIM:607364","sourceIds":["OMIM:607364"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-49c340585fd39dd90d7d"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000610","HP:0008046","HP:0000591","HP:0001944","HP:0003324","HP:0000841","HP:0002914"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":3,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":19,"sourceGroups":{"omim":16,"published":3}},"features":[{"hpoId":"HP:0000610","label":"Abnormal choroid morphology","primary":true},{"hpoId":"HP:0008046","label":"Abnormal retinal vascular morphology","primary":true},{"hpoId":"HP:0000591","label":"Abnormal sclera morphology","primary":true},{"hpoId":"HP:0001944","label":"Dehydration","primary":true},{"hpoId":"HP:0003324","label":"Generalized muscle weakness","primary":true},{"hpoId":"HP:0000841","label":"Hyperactive renin-angiotensin system","primary":true},{"hpoId":"HP:0002914","label":"Hyperchloriduria","primary":true},{"hpoId":"HP:0003127","label":"Hypocalciuria","primary":false},{"hpoId":"HP:0002900","label":"Hypokalemia","primary":false},{"hpoId":"HP:0001960","label":"Hypokalemic metabolic alkalosis","primary":false},{"hpoId":"HP:0002615","label":"Hypotension","primary":false},{"hpoId":"HP:0005579","label":"Impaired renal tubular reabsorption of chloride","primary":false},{"hpoId":"HP:0000859","label":"Increased circulating aldosterone concentration","primary":false},{"hpoId":"HP:0000848","label":"Increased circulating renin concentration","primary":false},{"hpoId":"HP:0003081","label":"Increased urinary potassium","primary":false},{"hpoId":"HP:0000121","label":"Nephrocalcinosis","primary":false},{"hpoId":"HP:0000103","label":"Polyuria","primary":false},{"hpoId":"HP:0000128","label":"Renal potassium wasting","primary":false},{"hpoId":"HP:0000127","label":"Renal salt wasting","primary":false}],"ledeHtml":"A form of Bartter syndrome characterized by a later age at onset than the other types of Bartter syndrome, typically presenting beyond the first year of life with failure to thrive, hypokalemic and hypochloremic metabolic alkalosis, increased levels of plasma renin and aldosterone and low to normal blood pressure.","mondoId":"MONDO:0011822","node":{"canonicalSlug":"bartter-disease-type-3","comparisons":[{"documentSha256":"fd9d87af07f5a6c412bffe0928986b3e6620ed94005d5c93959c7bf12fa724ac","key":"legacy-bartter","kind":"legacy","label":"Bartter syndrome","memberIds":["MONDO:0000909","MONDO:0009424","MONDO:0010503","MONDO:0011242","MONDO:0011822","MONDO:0015231","MONDO:0019524","MONDO:0100344"],"mondoId":"MONDO:0015231","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/bartter.fd9d87af07f5a6c412bffe0928986b3e6620ed94005d5c93959c7bf12fa724ac.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Bartter disease type 3","originalSourceId":"ORPHA:93605","paragraphs":["A form of Bartter syndrome characterized by a later age at onset than the other types of Bartter syndrome, typically presenting beyond the first year of life with failure to thrive, hypokalemic and hypochloremic metabolic alkalosis, increased levels of plasma renin and aldosterone and low to normal blood pressure."],"rawAttribution":"MONDO:0011822","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:40:41Z","upstream":"MONDO:0011822","url":"https://rarediseases.info.nih.gov/diseases/9659"},"ownColumnKeys":["population-49c340585fd39dd90d7d"],"publication":"published","relationships":[{"kind":"parent","label":"Bartter syndrome","mondoId":"MONDO:0015231","slug":"bartter"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"10561b4ee83cc6d7660e9b3bff175aa4c381f35601b90bb3cfb44ccbf2ab58eb","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:607364","disease_name":"Bartter syndrome, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000103","is_excluded":false,"label":"Polyuria","onset_id":null,"reference":"OMIM:607364","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"137f509a83dee47e8f544343147a1eafe74b5477a1ee863dc929c4435087ab11","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:607364","disease_name":"Bartter syndrome, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000591","is_excluded":false,"label":"Abnormal sclera morphology","onset_id":null,"reference":"OMIM:607364","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"1f1d15bb27a8f08aeefaadefdcfa41d049e8e43057f227f38699e2aa8a8faa06","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:607364","disease_name":"Bartter syndrome, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001944","is_excluded":false,"label":"Dehydration","onset_id":null,"reference":"OMIM:607364","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"24a8a1462fdf8000d6708830a7118685662e94b63372adef1e37d3ae3052d8cb","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:607364","disease_name":"Bartter syndrome, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000128","is_excluded":false,"label":"Renal potassium wasting","onset_id":null,"reference":"OMIM:607364","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"2a4cd57a61dae2b1335c0eef5b6c680b1091fe6a4c0cab48f78def3178bcc7ab","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:607364","disease_name":"Bartter syndrome, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000841","is_excluded":false,"label":"Hyperactive renin-angiotensin system","onset_id":null,"reference":"OMIM:607364","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"329fe0ff3937ea560c42e9109fb0598be3334a3c0289ec3b65c318155db654ef","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:607364","disease_name":"Bartter syndrome, type 3","evidence":"PCS","frequency_raw":"0/17","hpo_id":"HP:0000121","is_excluded":true,"label":"Nephrocalcinosis","onset_id":null,"reference":"PMID:9326936","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"394c01537e055ac3c410c2002d10436301063c449b4885bf5ef455753ac393b4","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:607364","disease_name":"Bartter syndrome, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002914","is_excluded":false,"label":"Hyperchloriduria","onset_id":null,"reference":"OMIM:607364","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"43c70a61d960a36d56784dc2bf945ef006d02cb34ff6878938594a04e059c26e","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:607364","disease_name":"Bartter syndrome, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0005579","is_excluded":false,"label":"Impaired renal tubular reabsorption of chloride","onset_id":null,"reference":"OMIM:607364","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"694e4b23bd9e2963259d5e871ea2dcf5c1d5d1410a07ca193c93298de5ace187","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:607364","disease_name":"Bartter syndrome, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000859","is_excluded":false,"label":"Increased circulating aldosterone concentration","onset_id":null,"reference":"OMIM:607364","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"69ee5150bcf367f437103314c092aeb15bee6bd75b22bda9c2389ea6c23cdded","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:607364","disease_name":"Bartter syndrome, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000610","is_excluded":false,"label":"Abnormal choroid morphology","onset_id":null,"reference":"OMIM:607364","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"7b101f3c4a33dafb908a8db8f0cad386340258a46b641942c76640da76cce6f7","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:607364","disease_name":"Bartter syndrome, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003081","is_excluded":false,"label":"Increased urinary potassium","onset_id":null,"reference":"OMIM:607364","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"849cdd3d54e6f2e648d3deb0c60f63b741d630ee8366d02afc45c3d66b0447b9","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:607364","disease_name":"Bartter syndrome, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002615","is_excluded":false,"label":"Hypotension","onset_id":null,"reference":"OMIM:607364","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"883a1f909a4d15280ef2d70a9f7533fd9c7e424f06302fae78a28568cd7d7f49","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:607364","disease_name":"Bartter syndrome, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0008046","is_excluded":false,"label":"Abnormal retinal vascular morphology","onset_id":null,"reference":"OMIM:607364","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"983c4257227bdf1ffd91609d7eef5ddf2142389c95e69d72f56c7203b1cd1049","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:607364","disease_name":"Bartter syndrome, type 3","evidence":"PCS","frequency_raw":"11/17","hpo_id":"HP:0003127","is_excluded":false,"label":"Hypocalciuria","onset_id":null,"reference":"PMID:9326936","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ae351dd68c5ff270f42e19ea1569d07e27258a1edee2a0ca6303f75703406679","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:607364","disease_name":"Bartter syndrome, type 3","evidence":"PCS","frequency_raw":"17/17","hpo_id":"HP:0002900","is_excluded":false,"label":"Hypokalemia","onset_id":null,"reference":"PMID:9326936","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"b8b2f2abdddbc919d37c166e135583e92bb7f72ecc4a008e1a86c54f9f7fc110","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:607364","disease_name":"Bartter syndrome, type 3","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000127","is_excluded":false,"label":"Renal salt wasting","onset_id":null,"reference":"OMIM:607364","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"d9d4bd2e1226a3135a0ebbca9ef90a7be4728fc271d1705fb007a458ccbb60ea","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:607364","disease_name":"Bartter syndrome, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003324","is_excluded":false,"label":"Generalized muscle weakness","onset_id":null,"reference":"OMIM:607364","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"f2f1e6ca893c29e3ffc0b6dd2c53d43868da70ff40444bade8eb968bcda0f42e","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:607364","disease_name":"Bartter syndrome, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000848","is_excluded":false,"label":"Increased circulating renin concentration","onset_id":null,"reference":"OMIM:607364","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"fb8ae9f5eaa91acf88ec91d4a2eea6f5ccbc96fc94aa9946ae087e28780a24d7","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:607364","disease_name":"Bartter syndrome, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001960","is_excluded":false,"label":"Hypokalemic metabolic alkalosis","onset_id":null,"reference":"OMIM:607364","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9659\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011822\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0011822</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A form of Bartter syndrome characterized by a later age at onset than the other types of Bartter syndrome, typically presenting beyond the first year of life with failure to thrive, hypokalemic and hypochloremic metabolic alkalosis, increased levels of plasma renin and aldosterone and low to normal blood pressure.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9659\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"bartter-disease-type-3","sourceDocuments":[{"name":"GARD: Bartter disease type 3","reviewed":null,"source_release":"2026-10-25T03:40:41Z","url":"https://rarediseases.info.nih.gov/diseases/9659"},{"name":"MONDO: Bartter disease type 3","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0011822"}],"sourceNote":"","synonyms":["adult Bartter syndrome","BARTS3","Bartter disease type 3","Bartter syndrome classic","Bartter syndrome type 3","Bartter syndrome type III"],"takeawayHtml":"","title":"Bartter disease type 3"},"schemaVersion":1}
